Mood changes during l-dopa therapy.
D000284:Administration, Oral; D000328:Adult; D000342:Affective Symptoms / Q000139:chemically induced*; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy
D004295:Dihydroxyphenylalanine